March 4, 2020
Kaken Pharmaceutical said on March 2 that its onychomycosis treatment Clenafin (efinaconazole) has been rolled out in Hong Kong through its local licensee. The Hong Kong drug maker Main Life Corp. launched on the same day the product under the...read more